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     IV 8  
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Early IQ Score: 
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     Year 1 87.9 (8.55) 
     Missing Year 1 1 (12.5%) 
     Year 2 93.4 (15.0) 
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Values are mean (SD) or N (%) unless otherwise indicated. 
   METHODS  
•  Assessed cognitive outcomes of 8 patients with Hurler 
syndrome: 
•  Transplanted at less than 12 months of age 
•  Transplanted since 2005 to reflect modern HCT 
practice 
•  All patients received ERT in peri tranplant period 
•  Longitudinal cognitive follow up data available at least 2 years 
following HCT for all patients. 
•  Examined cognitive scores before transplant and at 1 and 2 
years following HCT. 
•  Early IQ scores (IQ) were measured with the Mullen Scales of 
Early Learning and Bayley Scales of Infant and Toddler 
Development, Third Edition. 
•  Early IQ scores were analyzed longitudinally. Generalized 
estimating equations were used with robust variance estimation 
to determine the mean fit and p-value with an autoregressive 
(AR1) correlation structure to account for correlated 
observations. 
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  OBJECTIVE    To characterize cognitive outcomes of patients with  
Hurler syndrome transplanted prior to 12 months of 
life. 
   BACKGROUND  
•  Mucopolysaccharidosis (MPS) type I is a rare autosomal 
recessive LSD caused by deficiency in the enzyme α-L-
iduronidase. 
•  Severe form of MPSI, Hurler syndrome, is characterized by 
progressive neurological involvement and multisystem disease 
resulting in death by end of early childhood if untreated. 
•  Individuals with Hurler syndrome follow a predictable 
trajectory of normal cognitive development in first year of life, 
slowing in second year, and rapid decline thereafter.  
•  Allogeneic hematopoietic stem cell transplantation (HCT) is 
the standard of care as it stabilizes deterioration and extends 
survival. 
•  Enzyme replacement therapy (ERT) as an adjunct to HCT 
reduces morbidity and mortality and may lead to more 
favorable cognitive outcomes. 
•  Overwhelming evidence that earlier treatment with HCT leads 
to improved cognitive outcomes. 
 DISCUSSION  
•  No evidence of loss in IQ points from time period prior to HCT to 2 
years afterward. 
•  Likely cognitive benefit when transplant is conducted at younger 
than 12 months of life. 
•  Finding is different from the general literature which has a broader 
range of transplanted children and shows there is generally a loss of 
IQ points following HCT. 
•  Findings further support research that indicates earlier treatment 
leads to favorable outcomes. 
•  Important at the dawn of newborn screening. 
 FUTURE DRECTIONS  
•  Longer-term analyses of a larger cohort 
transplanted at less than 12 months to 
determine if cognitive outcomes remain 
superior from those transplanted at older 
ages. 
•  Compare this group to children 
transplanted at 12 months and older 
while controlling for additional factors 
such as baseline IQ, transplant 
preparation, and ERT. 
RESULTS 
IQ OVER TIME 
•  Five patients (62.5%) had a 2-year post-HCT 
IQ score equal to or higher than their 
baseline IQ score 
•  Average change = 12.4 points 
•  Three patients (37.5%) had a 2-year post-
HCT IQ score declined from baseline 
•  Average loss = 12.7 points 
•  IQ scores at 2 years following HCT were not different 
from baseline P = 0.63. 
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